Department of Health and Human Services August 6, 2008 – Federal Register Recent Federal Regulation Documents

Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride
Document Number: E8-18094
Type: Rule
Date: 2008-08-06
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia and Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of a ceftiofur hydrochloride injectable suspension for treatment of various bacterial infections in swine and cattle.
Oral Dosage Form New Animal Drugs; Amprolium
Document Number: E8-18093
Type: Rule
Date: 2008-08-06
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Phibro Animal Health. The supplemental NADA provides for label revisions associated with a previous change of sponsorship and other minor changes for amprolium concentrate solution to make medicated drinking water for chickens and turkeys for the treatment of coccidiosis. The product approval is being codified for the first time.
Oral Dosage Form New Animal Drugs; Oxfendazole Suspension
Document Number: E8-18092
Type: Rule
Date: 2008-08-06
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADA provides for revised scientific nomenclature for an internal parasite for which oxfendazole suspension is used orally in cattle.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Broadcast Advertisements
Document Number: E8-18091
Type: Notice
Date: 2008-08-06
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Customer/Partner Service Surveys
Document Number: E8-17906
Type: Notice
Date: 2008-08-06
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Customer/Partner Service Surveys'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Submission for OMB Review; Comment Request
Document Number: E8-17869
Type: Notice
Date: 2008-08-06
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration